SELERB INTERNATIONAL HEALTH LIMITED – Trademark Portfolio

Entity Type: 99

SELERB INTERNATIONAL HEALTH LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include HELERB, SELERB, and NADGENIE. The owner is based in HONG KONG.

RM 2112C, 21/F,WITTY COMM BUILDING,

HONG KONG 999077 , HK

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NADGENIE
NADGENIE
Registered 2024
HELERB
HELERB
Registered 2024
SELERB
SELERB
Registered 2024

Trademark Classifications

SELERB INTERNATIONAL HEALTH LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SELERB INTERNATIONAL HEALTH LIMITED have?

SELERB INTERNATIONAL HEALTH LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does SELERB INTERNATIONAL HEALTH LIMITED file in?

SELERB INTERNATIONAL HEALTH LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SELERB INTERNATIONAL HEALTH LIMITED's most well-known trademarks?

SELERB INTERNATIONAL HEALTH LIMITED's registered trademark portfolio includes well-known marks such as HELERB, SELERB, and NADGENIE. These are among 3 currently registered trademarks in the portfolio.

What is SELERB INTERNATIONAL HEALTH LIMITED's trademark registration success rate?

SELERB INTERNATIONAL HEALTH LIMITED has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.